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We recently demonstrated the role of M1 muscarinic receptors
(M1R) in modulating oxidative stress in liver and hepatocytes
(Urrunaga et al., 2015) [1]. Here we provide data regarding the
effect of a novel M1R agonist, VU0357017 (Lebois et al., 2010) [2],
on H2O2-mediated hepatocyte injury, the effect of an M1R
antagonist VU0255035 (Shefﬂer et al., 2009) [3] on catalase and
super oxide dismutase (SOD) activities in H2O2–treated hepato-
cytes in vitro, and ﬁnally, the effect of M1R ablation on hepatic
catalase activity in acetaminophen (APAP)-treated mice.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
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In response to oxidative stress:
 In contrast to M1R inhibition that reduces hepatocyte injury [1], M1R activation has no effect.
 In addition to enhancing GSH recovery [1], M1R inhibition enhances hepatic catalase activity.
 However, M1R inhibition has no effect on hepatocyte SOD activity.1. Data
Previously we showed in mice that M1R ablation reduces APAP-induced liver injury by preventing GSH
depletion and peroxynitrite generation, thereby reducing hepatocyte necrosis [1]. We also showed that in
AML12 hepatocytes (the non-transformed mouse hepatocytes), VU0255035 anM1R antagonist [3], reduced
H2O2-mediated necrosis, an effect abrogated by inhibition of GCLC, the key GSH generating enzyme. Here,
we show that unlike M1R antagonist (VU0255035) [1], the novel M1R agonist (VU0357017) [2] did not alter
H2O2-induced cytotoxicity ( Fig. 1). In hepatocytes incubated with H2O2, VU0255035 augmented catalase
activity but had no effect on SOD activity (Fig. 2). Finally, in mice, 2 h after APAP overdose, hepatic catalase
activity decreased; however, after 4 h, compared to wild type (WT) mice, catalase activity improved sig-
niﬁcantly in the livers of M1R-deﬁcient (Chrm1 /) mice (Fig. 3).) on H2O2-induced cytotoxicity assessed by MTT assay. (A) Incubation with 1 mM
tocyte viability. (B) Treatment with VU0357017 (0.3–3.0 mM) alone had no effect on
.M. ns: not signiﬁcant.
Fig. 2. Effects of a highly selective M1R antagonist VU0255035, on catalase and SOD activities were assessed in AML12
hepatocytes treated with 1 mM H2O2 for 120 min. Compared to cells treated with vehicle (DMSO) alone, catalase and SOD
activities were signiﬁcantly reduced in H2O2-treated cells. Co-treatment with VU0255035 improved catalase activity (A), but
had no effect on SOD activity (B). (C) VU0255035 alone had no effect on cell viability. Results are mean7S.E.M. * Po0.05, **
Po0.01.
Fig. 3. Effect of M1R ablation on APAP-induced changes in hepatic catalase activity. WT and Chrm1 / mice were fasted
overnight and treated with APAP 200 mg/kg intraperitoneally in the morning. Two and 4 h after APAP injection, mice were
euthanized and their livers harvested and analyzed as described previously [1]. By 2 h, hepatic catalase activity reduced sig-
niﬁcantly in all APAP-treated mice. However, by 4 h, catalase activity was signiﬁcantly higher in the livers of Chrm1 / mice
when compared to WT mice. Results are mean7S.E.M. * Po0.05.
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2.1. Experimental animals
Animal experiments were conducted in accordance with the Guide for the Care and Use of
Laboratory Animals prepared by the United States National Academy of Sciences (National Institutes of
Health), approved by the Institutional Animal Care and Use Committee, and described in detail
previously [1]. The stored liver tissue from the Chrm1 / and WT mice were used to assess catalase
activity.
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AML12, a non-tumorigenic mouse hepatocyte cell line (ATCC, USA), was cultured at 37 °C with 5%
CO2 in a 1:1 mixture of Dulbecco's modiﬁed Eagle's and Ham's F12 mediumwith 0.005 mg/ml insulin,
0.005 mg/ml transferrin, 5 ng/ml selenium, and 10% fetal bovine serum. Cells were sub-cultured (1:4
to 1:6) using a 0.25% (w/v) trypsin-0.53 mM EDTA solution.
2.3. Cytotoxicity assay
AML12 cells (6.0103 cells/well) were cultured in 96-well plates in the presence of 1 mM H2O2
plus vehicle (DMSO) or VU0357017 (0.3–3 μM) (PubChem CID: 25010775), the M1R agonist (Tocris,
USA). After 6 h, the culture media was replaced with 100 μl MTT (0.5 mg/ml in culture media) and
incubated at 37 °C. After 2.5 h, the MTT solution was discarded, all wells washed with PBS, and added
150 μl DMSO each. The plate was kept at room temperature for 30 min with constant shaking, and
absorbance read at 540 nm (VersaMax Microplate Reader, Molecular Device).
2.4. Preparation of cell extracts
AML12 cells (1105 cells/well) were maintained in six-well plates in the presence of 1 mM H2O2
and vehicle or 1 mM VU0255035 (PubChem CID: 24768606). After 2 h, cells were lysed using a
polytron homogenizer using isolation buffer (250 mM sucrose, 10 mM Tris HCL pH 7.4, and
0.1 mM EGTA).
2.5. Superoxide dismutase activity assay
SOD activity was estimated as described previously [4]. Reaction mixture contained 0.1 ml phe-
nazine methosulphate (186 μM), 1.2 ml sodium pyrophosphate buffer (0.052 mM, pH 7.0) and 0.3 ml
cell supernatant. Enzyme reaction was initiated by adding 0.2 ml NADH (780 μM) and terminated
after 1 min by adding 1 ml glacial acetic acid. The chromogen formed was assessed by measuring
absorbance at 560 nm on BioMate 3S Spectrophotometer (Thermo Scientiﬁc, USA). Results are
expressed in units/mg protein.
2.6. Catalase activity assay
Catalase activity was assessed in cellular and tissue fractions as described earlier [5]. Brieﬂy, the
activity was determined by measuring the decrease in absorbance at 240 nm of a reaction mixture
consisting H2O2 in phosphate buffer, pH 7.0, and cellular/tissue extracts. The molar extinction coef-
ﬁcient of 43.6 M cm1 was used to determine catalase activity and expressed as units/mg protein.
2.7. Statistical analysis
All data are expressed as mean7S.E.M. Normality was determined using the Shapiro–Wilk test.
Student's t-test (normally distributed data) or the Mann–Whitney U test (nonparametric data) was
used to determine signiﬁcance. Analysis was performed using SigmaPlot (version 12.0; Systat Soft-
ware, Inc. San Jose, CA). Signiﬁcance was deﬁned as Po0.05.Acknowledgments
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